Viva Biotech Holdings engages in the discovery, development, and manufacturing of clinical drugs. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2019-05-09. The firm has two segments. The Drug Discovery Services segment provides structure-based drug discovery services to biotech and pharmaceutical clients for preclinical innovative drug development. The Contract Design and Manufacturing (CDMO) and Commercialization Services segment is engaged in contract development and manufacturing services for small molecule Active Pharmaceutical Ingredients (APIs) and intermediates, as well as the trading of APIs, intermediates and finished products. The firm conducts business primarily in the United States, China, Europe and other regions.
Follow-Up Questions
Qui est le CEO de VIVA Biotech Holdings ?
Mr. Chen Cheney Mao est le Executive Chairman of the Board de VIVA Biotech Holdings, il a rejoint l'entreprise depuis 2018.
Quelle est la performance du prix de l'action VBIZF ?
Le prix actuel de VBIZF est de $0.295, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de VIVA Biotech Holdings ?
VIVA Biotech Holdings appartient à l'industrie Life Sciences Tools & Services et le secteur est Health Care
Quel est la capitalisation boursière de VIVA Biotech Holdings ?
La capitalisation boursière actuelle de VIVA Biotech Holdings est de $622.3M
Est-ce que VIVA Biotech Holdings est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 3 analystes ont établi des notations d'analystes pour VIVA Biotech Holdings, y compris 3 achat fort, 3 achat, 1 maintien, 0 vente et 3 vente forte
